Selected research
Industry Growth & Trends
Global Pseudouridine Industry Growth and Trends Forecast to 2032
Market perspective
The global Pseudouridine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pseudouridine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pseudouridine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pseudouridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pseudouridine include Biosynth Carbosynth, BOC Sciences, Jena Bioscience, MP Biomedicals, Inc, TCI, Toronto Research Chemical, TriLink BioTechnologies, Ulcho Biochemical Ltd (FCAD Group) and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pseudouridine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pseudouridine market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pseudouridine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pseudouridine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pseudouridine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pseudouridine Market by Company
Biosynth Carbosynth
BOC Sciences
Jena Bioscience
MP Biomedicals, Inc
TCI
Toronto Research Chemical
TriLink BioTechnologies
Ulcho Biochemical Ltd (FCAD Group)
Thermo Fisher Scientific
YAMASA Corporation
Shanghai Hongene Biotech
Wuhan Finetech
Wuhan Glycogene
Pseudouridine Segment by Type
Powder
Solution
Pseudouridine Segment by Application
Vaccines and Other RNA Medicines
Scientific Research
Pseudouridine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pseudouridine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pseudouridine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pseudouridine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pseudouridine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pseudouridine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Solution
Applications
- Vaccines and Other RNA Medicines
- Scientific Research
Companies covered
- Biosynth Carbosynth
- BOC Sciences
- Jena Bioscience
- MP Biomedicals, Inc
- TCI
- Toronto Research Chemical
- TriLink BioTechnologies
- Ulcho Biochemical Ltd (FCAD Group)
- Thermo Fisher Scientific
- YAMASA Corporation
- Shanghai Hongene Biotech
- Wuhan Finetech
- Wuhan Glycogene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pseudouridine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pseudouridine Sales Estimates and Forecasts (2021-2032)
- 1.3 Pseudouridine Market by Type
- 1.3.1 Powder
- 1.3.2 Solution
- 1.4 Global Pseudouridine Market Size by Type
- 1.4.1 Global Pseudouridine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pseudouridine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pseudouridine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pseudouridine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pseudouridine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pseudouridine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pseudouridine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pseudouridine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pseudouridine Industry Trends
- 2.2 Pseudouridine Industry Drivers
- 2.3 Pseudouridine Industry Opportunities and Challenges
- 2.4 Pseudouridine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pseudouridine Revenue (2021-2026)
- 3.2 Global Top Players by Pseudouridine Sales (2021-2026)
- 3.3 Global Top Players by Pseudouridine Price (2021-2026)
- 3.4 Global Pseudouridine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pseudouridine Major Company Production Sites & Headquarters
- 3.6 Global Pseudouridine Company, Product Type & Application
- 3.7 Global Pseudouridine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pseudouridine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pseudouridine Players Market Share by Revenue in 2025
- 3.8.3 2025 Pseudouridine Tier 1, Tier 2, and Tier 3
4 Pseudouridine Regional Status and Outlook
- 4.1 Global Pseudouridine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pseudouridine Historic Market Size by Region
- 4.2.1 Global Pseudouridine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pseudouridine Sales in Value by Region (2021-2026)
- 4.2.3 Global Pseudouridine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pseudouridine Forecasted Market Size by Region
- 4.3.1 Global Pseudouridine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pseudouridine Sales in Value by Region (2027-2032)
- 4.3.3 Global Pseudouridine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pseudouridine by Application
- 5.1 Pseudouridine Market by Application
- 5.1.1 Vaccines and Other RNA Medicines
- 5.1.2 Scientific Research
- 5.2 Global Pseudouridine Market Size by Application
- 5.2.1 Global Pseudouridine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pseudouridine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pseudouridine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pseudouridine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pseudouridine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pseudouridine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pseudouridine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pseudouridine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Biosynth Carbosynth
- 6.1.1 Biosynth Carbosynth Company Information
- 6.1.2 Biosynth Carbosynth Business Overview
- 6.1.3 Biosynth Carbosynth Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Biosynth Carbosynth Pseudouridine Product Portfolio
- 6.1.5 Biosynth Carbosynth Recent Developments
- 6.2 BOC Sciences
- 6.2.1 BOC Sciences Company Information
- 6.2.2 BOC Sciences Business Overview
- 6.2.3 BOC Sciences Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BOC Sciences Pseudouridine Product Portfolio
- 6.2.5 BOC Sciences Recent Developments
- 6.3 Jena Bioscience
- 6.3.1 Jena Bioscience Company Information
- 6.3.2 Jena Bioscience Business Overview
- 6.3.3 Jena Bioscience Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Jena Bioscience Pseudouridine Product Portfolio
- 6.3.5 Jena Bioscience Recent Developments
- 6.4 MP Biomedicals, Inc
- 6.4.1 MP Biomedicals, Inc Company Information
- 6.4.2 MP Biomedicals, Inc Business Overview
- 6.4.3 MP Biomedicals, Inc Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 MP Biomedicals, Inc Pseudouridine Product Portfolio
- 6.4.5 MP Biomedicals, Inc Recent Developments
- 6.5 TCI
- 6.5.1 TCI Company Information
- 6.5.2 TCI Business Overview
- 6.5.3 TCI Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 TCI Pseudouridine Product Portfolio
- 6.5.5 TCI Recent Developments
- 6.6 Toronto Research Chemical
- 6.6.1 Toronto Research Chemical Company Information
- 6.6.2 Toronto Research Chemical Business Overview
- 6.6.3 Toronto Research Chemical Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Toronto Research Chemical Pseudouridine Product Portfolio
- 6.6.5 Toronto Research Chemical Recent Developments
- 6.7 TriLink BioTechnologies
- 6.7.1 TriLink BioTechnologies Company Information
- 6.7.2 TriLink BioTechnologies Business Overview
- 6.7.3 TriLink BioTechnologies Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 TriLink BioTechnologies Pseudouridine Product Portfolio
- 6.7.5 TriLink BioTechnologies Recent Developments
- 6.8 Ulcho Biochemical Ltd (FCAD Group)
- 6.8.1 Ulcho Biochemical Ltd (FCAD Group) Company Information
- 6.8.2 Ulcho Biochemical Ltd (FCAD Group) Business Overview
- 6.8.3 Ulcho Biochemical Ltd (FCAD Group) Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Ulcho Biochemical Ltd (FCAD Group) Pseudouridine Product Portfolio
- 6.8.5 Ulcho Biochemical Ltd (FCAD Group) Recent Developments
- 6.9 Thermo Fisher Scientific
- 6.9.1 Thermo Fisher Scientific Company Information
- 6.9.2 Thermo Fisher Scientific Business Overview
- 6.9.3 Thermo Fisher Scientific Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Thermo Fisher Scientific Pseudouridine Product Portfolio
- 6.9.5 Thermo Fisher Scientific Recent Developments
- 6.10 YAMASA Corporation
- 6.10.1 YAMASA Corporation Company Information
- 6.10.2 YAMASA Corporation Business Overview
- 6.10.3 YAMASA Corporation Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 YAMASA Corporation Pseudouridine Product Portfolio
- 6.10.5 YAMASA Corporation Recent Developments
- 6.11 Shanghai Hongene Biotech
- 6.11.1 Shanghai Hongene Biotech Company Information
- 6.11.2 Shanghai Hongene Biotech Business Overview
- 6.11.3 Shanghai Hongene Biotech Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Shanghai Hongene Biotech Pseudouridine Product Portfolio
- 6.11.5 Shanghai Hongene Biotech Recent Developments
- 6.12 Wuhan Finetech
- 6.12.1 Wuhan Finetech Company Information
- 6.12.2 Wuhan Finetech Business Overview
- 6.12.3 Wuhan Finetech Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Wuhan Finetech Pseudouridine Product Portfolio
- 6.12.5 Wuhan Finetech Recent Developments
- 6.13 Wuhan Glycogene
- 6.13.1 Wuhan Glycogene Company Information
- 6.13.2 Wuhan Glycogene Business Overview
- 6.13.3 Wuhan Glycogene Pseudouridine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Wuhan Glycogene Pseudouridine Product Portfolio
- 6.13.5 Wuhan Glycogene Recent Developments
7 North America by Country
- 7.1 North America Pseudouridine Sales by Country
- 7.1.1 North America Pseudouridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pseudouridine Sales by Country (2021-2026)
- 7.1.3 North America Pseudouridine Sales Forecast by Country (2027-2032)
- 7.2 North America Pseudouridine Market Size by Country
- 7.2.1 North America Pseudouridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pseudouridine Market Size by Country (2021-2026)
- 7.2.3 North America Pseudouridine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pseudouridine Sales by Country
- 8.1.1 Europe Pseudouridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pseudouridine Sales by Country (2021-2026)
- 8.1.3 Europe Pseudouridine Sales Forecast by Country (2027-2032)
- 8.2 Europe Pseudouridine Market Size by Country
- 8.2.1 Europe Pseudouridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pseudouridine Market Size by Country (2021-2026)
- 8.2.3 Europe Pseudouridine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pseudouridine Sales by Country
- 9.1.1 Asia-Pacific Pseudouridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pseudouridine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pseudouridine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pseudouridine Market Size by Country
- 9.2.1 Asia-Pacific Pseudouridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pseudouridine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pseudouridine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pseudouridine Sales by Country
- 10.1.1 South America Pseudouridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pseudouridine Sales by Country (2021-2026)
- 10.1.3 South America Pseudouridine Sales Forecast by Country (2027-2032)
- 10.2 South America Pseudouridine Market Size by Country
- 10.2.1 South America Pseudouridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pseudouridine Market Size by Country (2021-2026)
- 10.2.3 South America Pseudouridine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pseudouridine Sales by Country
- 11.1.1 Middle East and Africa Pseudouridine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pseudouridine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pseudouridine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pseudouridine Market Size by Country
- 11.2.1 Middle East and Africa Pseudouridine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pseudouridine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pseudouridine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pseudouridine Value Chain Analysis
- 12.1.1 Pseudouridine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pseudouridine Production Mode & Process
- 12.2 Pseudouridine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pseudouridine Distributors
- 12.2.3 Pseudouridine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst